Ligand validation:8HB9

R1R: [2-[2-[[1-[4-[(1S)-1-[[5-fluoranyl-4-[(4S)-2-oxidanylidene-4-propan-2-yl-1,3-oxazolidin-3-yl]pyrimidin-2-yl]amino]ethyl]phenyl]piperidin-4-yl]sulfamoyl]ethylsulfanylmethyl]-3-oxidanylidene-propyl]-trimethyl-azanium

R1R is a Ligand Of Interest in 8HB9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8HB9_R1R_CCC_501	60%	6%	0.124	0.946	2.47	2.59	7	20	0	0	79%	0.7872
8HB9_R1R_BBB_501	60%	5%	0.125	0.947	2.66	2.7	11	19	0	0	79%	0.7872
8HB9_R1R_DDD_501	54%	6%	0.138	0.942	2.55	2.52	10	17	0	0	79%	0.7872
8HB9_R1R_AAA_501	53%	7%	0.136	0.936	2.4	2.4	9	19	0	0	79%	0.7872

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.